 |
Just Released
|
|
|
Use of Telemedicine for Sexual and
Reproductive Health Is Low – Despite Potential to Improve Access to Care
Telemedicine holds the potential
to expand access to contraceptives, STI testing and treatment and abortion
care, yet few individuals use this approach to obtain these services. A new KFF analysis examines the opportunities of
telemedicine to expand access to sexual and reproductive health care as well
as the policy barriers impeding its expansion. Because each state defines and
regulates telemedicine differently, the availability and coverage of services
is inconsistent across the country. While no state explicitly prohibits
the use of telemedicine for contraception or STIs -- 18 states have
effectively banned telemedicine approaches to provide medication abortion.
Many of the states that have recently passed abortion restrictions that have
led to clinic closures also have laws that block the use of telemedicine to
distribute mifepristone, even though research finds it to be safe, effective
and acceptable to patients when compared to in-person care.
The brief also outlines the growing use of telemedicine for contraception and STI care, including a discussion of insurance coverage of telemedicine services, the financial implications for providers and patients and its potential to improve access to reproductive health care across the United States.
Filling the need for trusted information on
national health issues, the Kaiser Family Foundation is a nonprofit organization based
in San Francisco, California.
|
||
|
||
|
Connect with us:
    |
||
Monday, November 25, 2019
Use of Telemedicine for Sexual and Reproductive Health Is Low – Despite Potential to Improve Access to Care
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment